Daniel Camardo

Daniel Camardo

Director/Board Member at CUE BIOPHARMA, INC.

Net worth: 556 336 $ as of 31/08/2026

57 year
Health Technology
Consumer Services
Health Services

Profile

Mr. Daniel A. Camardo is on the Board of Directors at Cue Biopharma, Inc. and CommunityHealth NFP.
Mr. Camardo was previously employed as a President-North America by Immedica Pharma AB, a Chief Executive Officer, Secretary, Director & CAO by Athersys, Inc., a President-US & Executive Vice President by Horizon Therapeutics Ltd. (Ireland), a Vice President-Sales & Operations by Clarus Therapeutics, Inc., and a Senior Director-US Commercial Operations by Astellas Pharma US, Inc. He received his undergraduate degree from Rochester Christian University and an MBA from Kellogg School of Management.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
09/07/2026 21,800 ( 0.3% ) 556 336 $ 31/08/2026

Daniel Camardo active positions

CompaniesPositionStart
CUE BIOPHARMA, INC. Director/Board Member 30/05/2026
Director/Board Member -

Former positions of Daniel Camardo

CompaniesPositionEnd
ATHERSYS, INC. Chief Executive Officer 31/12/2023
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY Corporate Officer/Principal 01/02/2022
Sales & Marketing 01/09/2015
Corporate Officer/Principal 01/01/2004
Corporate Officer/Principal -
See the detail of Daniel Camardo's experience

Training of Daniel Camardo

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

63

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Consumer Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Daniel Camardo